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iscrimination of Myocardial Acute
nd Chronic (Scar) Infarctions on Delayed
ontrast Enhanced Magnetic Resonance Imaging
ith Intravascular Magnetic Resonance Contrast Media
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OBJECTIVES The purpose of this study was to examine the potential of intravascular gadolinium (Gd)-chelates
in discriminating acute from chronic myocardial infarctions (MIs).
BACKGROUND A potential limitation of delayed contrast enhanced magnetic resonance imaging with
standard extracellular Gd-chelates is its inability to distinguish acute from chronic MIs.
METHODS Eight pigs with MIs were studied at 3 days and 8 weeks. Inversion recovery gradient echo
(IR-GRE), T1-turbo spin echo (TSE), and T2-TSE images were acquired before and after
administration of intravascular and extracellular Gd-chelates. Triphenyltetrazolium chloride
(TTC) was used to delineate infarctions at postmortem. Masson’s trichrome and Biotinylated
Bandeiria simplicifolia Isolectin B4 stains were used to characterize scarred myocardium.
Analysis of variance was used to compare signal intensity (SI) ratios and determine differences
in infarct extent.
RESULTS The intravascular agent produced differential enhancement of acute infarctions at 3 days (SI
ratio 5.8  1.3) but not at 8 weeks (1.6  0.4, p  0.01). The extracellular agent provided
differential enhancement of both acute (SI ratio 7.7  1.4) and chronic (7.5  0.9)
infarctions. The extents of enhanced regions in acute infarctions were not different after
intravascular (16.0  1.3%) or extracellular (17.1  1.7%) agents; at 8 weeks the extent of
extracellular enhanced and TTC regions were smaller (13.2  1.4% and 12.0  1.5%,
respectively). Masson’s trichrome stain demonstrated dense scar tissue, signaling the complete
healing of infarction. The vascular stain showed that scar tissue contained fewer microvessels
oriented in a haphazard array.
CONCLUSIONS The combination of intravascular and extracellular Gd-chelates discriminates acute from
chronic infarctions on delayed images. This double contrast agent approach can be used to
determine the age and extent of infarctions. (J Am Coll Cardiol 2006;48:1961–8) © 2006
















oelayed contrast enhanced magnetic resonance imaging
MRI) has been shown to be highly effective for demarcat-
ng infarcted from normal myocardium (1–4). It is now
lear that delayed enhancement occurs for both acute
necrosis) and chronic (scar) myocardial infarctions (MIs);
s such it can be useful in various clinical circumstances. In
cute cases, it is capable of distinguishing infarcted from
tunned myocardium and confidently excluding MI in the
etting of acute chest pain. Furthermore, in chronic cases,
uch as ischemic cardiomyopathy, it can be used to distin-
uish viable hibernating from infarcted myocardium (1).
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006, accepted March 1, 2006.uch discrimination allows for the prediction of recovery of
ysfunctional myocardium after revascularization.
A limitation of delayed contrast enhancement MRI with
tandard extracellular gadolinium (Gd)-chelates is its inabil-
ty to distinguish acute from chronic infarctions (5,6). This
imitation might have relevance in some clinical scenarios,
uch as acute chest pain in patients with prior infarctions or
etection of intraoperative or postoperative infarction in
atients with prior infarction.
It was also demonstrated that intravascular Gd-chelates
nhance acute infarctions (7–9). Because the distribution vol-
me and mechanism of distribution of intravascular and
xtracellular MR contrast agents differ considerably (9,10), the
nhancement pattern in acute myocardial infarctions (AMIs)
nd chronic infarctions might also be different. This seems
ikely because vascular integrity is destroyed in acutely infarcted
yocardium but is intact in scar tissue (11–14). The hypothesis
f the current study was that intravascular Gd-chelates produce





























































































1962 Saeed et al. JACC Vol. 48, No. 10, 2006
MR in AMIs and Scar Tissue November 21, 2006:1961–8ETHODS
ntravascular and extracellular MR contrast media. The
ntravascular contrast agent (P792, Vistarem, Guerbet
roup, Paris, France) is a Gd macrocyclic compound
ased on the structure of extracellular MR contrast agent
d–1,4,7,10-tetraazacyclodecane-N,N1,N11,N111-
etraacetic acid (DOTA) (Dotarem, Guerbet) supple-
ented by hydrophilic arms (Guerbet) (15). Preliminary
tudies in healthy volunteers have indicated that this agent
roduces no side effects (16). The chemical structure of the
ew intravascular contrast agent has been optimized to
rovide: 1) a high r1 relaxivity for MRI, 2) a high biocom-
atibility profile, and 3) a large molecular volume.
The relaxivities, r1 and r2, of the intravascular contrast
gent were 29 and 65 l · mmol1 · s1, respectively, in 4%
uman serum albumin (HSA) at 37°C and 60 MHz (1.5 T).
he r1 and r2 of the extracellular agent were 3.5 and
.2 l · mmol1 · s1, respectively, at 60 MHz (1.5 T). This
ew agent has a molecular mass of 6,473 D, and a diameter
f 5 nm, which restricts fast diffusion out of normal
icrovessels but is small enough to be filtered by the kidney.
he extracellular agent has a molecular mass of 561 D, and
0.9-nm diameter, which allows its distribution in the
nterstitium as well (17,18).
Preliminary studies were conducted in 4 pigs with a
ower dose of 0.013 mmol/kg intravascular agent as
ecommended in previous studies (19,20). In these 4 ani-
als, 0.013 mmol/kg produced poor enhancement of
cutely infarcted myocardium. A higher dose (0.026 mmol/
g) was subsequently used in the 8 animals of this study.
his concentration is one-fourth of the recommended dose
0.1 mmol/kg) of extracellular Gd-chelates on a molar Gd
asis.
urgical procedure. This investigation conformed to the
uide for the Care and Use of Laboratory Animals pub-
ished by the National Institutes of Health (Publication No.
5-23, revised 1996). Eight pigs were pre-medicated with
etamine (20 mg/kg), xylazine (2 mg/kg), and atropine
0.04 mg/kg) and anesthetized by isoflurane/oxygen (1.5%
o 2.0%). After median sternotomy, the left anterior de-
Abbreviations and Acronyms
AMI  acute myocardial infarction
D  Dalton
Gd  gadolinium
IR-GRE  inversion recovery gradient echo
LV  left ventricle/ventricular
MI  myocardial infarction
MRI  magnetic resonance imaging
SI  signal intensity
TE  echo time
TR  repetition time
TSE  turbo spin echo
TTC  triphenyltetrazolium chloridecending coronary artery was isolated at the second diagonal vnd occluded for 2 h, followed by reperfusion. Arterial
lood pressure and heart rate were recorded during imaging
ia a femoral catheter.
At 3 days and 8 weeks after infarction, animals were
e-anesthetized and MRI studies were acquired. Eight
eeks after infarction is widely considered chronic infarc-
ion in humans (21), pigs (22), sheep (23,24), and dogs (6).
nimals were then killed, and the hearts were excised and
liced (10 mm). Slices were stained with triphenyltetrazo-
ium chloride (TTC) (2% at 37°C) to delineate scar tissue.
he body weight increased from 30 to 32 kg at 3 days to 52
o 55 kg at 8 weeks.
RI. A 1.5-T MR scanner (Philips Medical Systems,
est, the Netherlands) was used. A 5-element phased-array
ardiac coil was wrapped around the chest. Three pulse
equences were used: 1) T2-turbo spin echo (TSE), 2)
nversion recovery gradient echo (IR-GRE), and 3) T1-
SE. The T1-TSE sequence was used in this study to confirm
he IR-GRE findings. The following parameters were used:
cho time (TE) / repetition time (TR)  2.1/4.4 ms for
R-GRE, TE/TR  20 ms/1 R-R interval for T1-TSE, and
E/TR 100 ms/2 R-R interval for T2-TSE. The inversion
imes used for IR-GRE sequences were optimized to null
ormal myocardial signal (350 to 475 ms for baseline, 275 to
00 ms for intravascular enhanced, and 250 to 350 ms for
he extracellular enhanced images). A contiguous long-axis
iew was necessary to determine the short-axis view on
R-GRE and T1-TSE. Images encompassing the entire left
entricle (LV) were acquired at baseline and 10, 25, and 40
in after administration of the intravascular agent. After 75
in, a 0.1-mmol/kg extracellular agent was administered.
nversion recovery gradient echo and T1-TSE images were
cquired after 20 min. The extent of infarctions and regional
ignal intensity (SI) of infarcted and normal myocardium
ere measured on all slices (10 mm) by 2 observers. The SI
atios were calculated by dividing SI of the infarct by remote
yocardium. A threshold of 2 SD above the mean SI of
emote myocardium was used to define the infarcted
egion (25).
istology. Postmortem tissue samples were obtained from
ormal, interface between remote and scarred myocardium
peri-infarction zone), and scar tissue. The samples were
xed in 10% formalin and embedded in paraffin. Sections
5 m) were stained with hematoxylin and eosin. Masson’s
richrome stain was used to define scarred myocardium.
iotinylated Bandeiria simplicifolia Isolectin B4 (Vector
aboratories, Burlingame, California) was used to specifi-
ally localize vascular endothelial cells (26).
tatistical analysis. The spatial extent of enhancement was
xpressed as a percentage of LV mass on a slice-by-slice
asis. The MR sections and TTC slices were matched on
he basis of anatomic landmarks, which include LV shape,
apillary muscle shape, and the location and insertion point
f the right ventricle. Breath hold during the acquisition of
he volumetric data was used to minimize the spatial
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November 21, 2006:1961–8 MR in AMIs and Scar Tissuerecise correlation, short-axis planes were used in MRI and
istological slices. In TTC the mean of the upper and lower
aces of each slice was calculated. Thus, the nesting effect
layed a negligible role in the measurements. The statistical
ifferences between mean values (mean SEM) of SI ratios
nd the extent of infarctions on MR images were evaluated
ith the use of StatView 5.0 (SAS Institute, Cary, North
arolina). Analysis of variance was used to compare the
hanges in SI ratio versus time. It was also used to
etermine differences in the extent of infarctions on contrast
nhanced images and TTC histochemical staining. This
as followed by Scheffe’s F test. The null hypothesis was
ejected for p  0.05.
ESULTS
MIs. Acute myocardial infarctions were visible on T2-
SE (SI ratio  1.5  0.1) (Fig. 1) but not on IR-GRE
1.0  0.1) or T1-TSE (1.0  0.1). After the administra-
ion of intravascular and extracellular agents, all acutely
nfarcted hearts (n 8) showed delayed enhancement (Figs.
and 3). The intravascular Gd-chelate did not enhance
hronic infarctions (Figs. 2 and 3). Mean changes in SI ratio
ersus time on contrast enhanced IR-GRE and T1-TSE
equences are shown in Figure 4. At 40 min after admin-
stration of intravascular Gd-chelate, the SI ratio was 5.6 
.3 on IR-GRE and 1.5  0.1 on T1-TSE sequence for
cute infarctions (Fig. 5). These data indicate that IR-GRE
s superior to the T1-TSE sequence. The extracellular
d-chelate provided significantly greater enhancement on
R-GRE images (SI ratio was 7.7  1.4, p  0.01) than
nhanced T1-TSE and differential contrast on T2-TSE
mages.
hronic infarctions (scar tissue). The intravascular Gd-
helate did not provide differential enhancement in chronic
nfarctions over the course of 40 min (Fig. 4) on either
R-GRE or T1-TSE images. The magnitude of signal
nhancement of remote myocardium after administration of
igure 1. Long- and short-axis views T2-turbo spin echo. Magnetic reson
ot chronic (center) infarctions showed differential enhancement (arrows). The
owing blood adjacent to infarction. Triphenyltetrazolium chloride staining (righe intravascular agent was not significantly different be-
ween chronic (5.4  0.31 before contrast injection and
.8  0.25 after) and acute (5.8  0.46 arbitrary units
efore and 8.7  0.61 at 5 min after injection) infarctions
n T1-TSE images. A similar finding was observed on
R-GRE (1.1  0.1). Of note, the extracellular Gd-chelate
rovided equivalent enhancement of chronic infarctions (SI
atio  7.5  0.9), as it did in acute infarctions (SI ratio 
.7  1.4), on IR-GRE (Fig. 5). Chronic infarctions did
ot show differential increase in SI compared with normal
yocardium on T2-TSE or T1-TSE after administration of
ntravascular Gd-chelate (SI ratio  1.1  0.1).
nfarction extent. The extents of acute infarctions were
ot significantly different after administration of extracellu-
ar (17.1 3.1% of LV mass) and intravascular Gd-chelates
16.0  1.3%). The extents of the enhanced regions were
maller (13.2  1.4% of LV mass, p  0.01) at 8 weeks than
t 3 days but comparable to true infarctions on TTC (12.0 
.5% of LV mass, p  NS). The LV mass/body weight
atios (g/kg) showed no significant increase over the course
f 8 weeks (3.00  0.12 at 3 days and 2.92  0.15 at
weeks). The extents of chronic infarctions were not
easured on T1-TSE after administration of intravascular
ontrast agent or T2-TSE, because these sequences did not
rovide differential contrast.
emodynamic measurements. In acute and chronic in-
arctions, the heart rates were 94  5 beats/min and 89 
beats/min (p  NS) and the mean arterial pressures were
1 1 mm Hg and 73 4 mm Hg (p NS), respectively.
dministration of intravascular and extracellular Gd-
helates caused no significant change in the mean systolic
94  2 to 90  3 mm Hg) or diastolic (54  2 to 57  3
m Hg) blood pressures in acute and chronic infarctions.
imilarly, there was no significant change in arterial oxygen
aturation (96  2% vs. 97  3%) after contrast injections.
istology. Hematoxylin and eosin and Mason’s trichrome
tains showed no evidence of dense collagen or remodeled
images acquired from 2 animals (top and bottom rows). Acute (left) butance
bright signal in the left ventricular chambers (arrowheads) represents slow
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MR in AMIs and Scar Tissue November 21, 2006:1961–8lood vessels in remote myocardium. Biotinylated Bandeiria
implicifolia isolectin B4 stain showed numerous and uni-
ormly distributed microvessels coursing in parallel with
yofibers. However, scar tissue consisted of dense collagen
nd remodeled, sparse, and large thick-walled blood vessels
Fig. 6). Masson’s trichrome stain showed dense fibrous
issue signaling complete healing of infarction. Biotinylated
andeiria simplicifolia isolectin B4 stain stained vascular
ndothelial cells brown. This stain showed the scarcity and
aphazard orientation of intact microvessels in scar tissue
ompared with remote myocardium.
ISCUSSION
he major findings of this study are the following: 1)
ntravascular Gd-chelate can discriminate AMI from scar
issue, and 2) the extents of acute infarctions delineated by
ntravascular Gd-chelate are the same as that shown by
tandard extracellular Gd-chelate. There was no delayed
nhancement produced by intravascular Gd-chelate in
hronic infarctions. The capability of distinguishing AMIs
rom scar tissue by intravascular Gd-chelate might be useful
or excluding: 1) a new acute infarction in the clinical setting
igure 2. Long- (rows A and D) and short-axis (rows B and E) views of in
ets of images). The extracellular and intravascular gadolinium-chelates pr
iew (rows A and D), the cores of acute infarctions show small patchy hyp
n chronic infarctions (center blocks, arrows) the extracellular agent pro
lices C and F) confirmed the extent and location of infarction (arrows).f known prior infarction or in the presence of ischemic Tardiomyopathy, and 2) intraoperative or postoperative
nfarction in a patient with known prior infarction after
evascularization.
There are other reported approaches for distinguishing
MIs from scar tissue (27–31). Egred et al. (27) indicated
hat scar tissue could be differentiated from viable myocar-
ium with T2* blood oxygen level dependent (BOLD)
RI. However, other investigators found difficulty in as-
essing the infero-lateral LV walls (the areas supplied by the
ight and circumflex coronary arteries) because of suscepti-
ility artifacts (28). In a recent study, Hillenbrand et al. (31)
ound that the combination of 23sodium and contrast
nhanced MRI provided temporal characterization of acute
nfarctions and infarct healing. A possible mechanism in-
olved in the decrease of 23sodium signal on MRI during
nfarct healing includes granulation and collagen deposition.
n another study Abdel-Aty et al. (30) used a combination
f triple inversion recovery T2-weighted and delayed con-
rast enhanced MR sequences to differentiate AMIs from
car tissue in 73 patients by showing myocardial edema in
cute infarctions. Patients (n  15) with MIs were studied
n day 1 and 3 months after infarction with black-blood,
n recovery gradient echo images acquired from 2 animals (top and bottom
d enhancement of acute infarctions (left blocks, arrows). In the long-axis
anced regions, an indication of the presence of microvascular obstruction.
differential enhancement. Triphenyltetrazolium chloride staining (rightversio
oduce
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November 21, 2006:1961–8 MR in AMIs and Scar TissueSE sequence used in the current study is less sensitive to
dema than the T2-weighted triple inversion recovery se-
uence employed in a previous study (30). This was shown
y a SI ratio of 1.5  0.1 on T2-TSE in the current study
ompared with 2.9  1.5 on T2-triple inversion recovery
equence. Acute MIs showed differential contrast (high
ignal) on T2-weighted sequences or enhancement by ex-
racellular and intravascular Gd-chelates. After 8 weeks the
nfarctions were no longer visible on T2-weighted sequences
r after administration of intravascular Gd-chelate. Con-
ersely, standard extracellular Gd-chelate produced differ-
ntial enhancement between infarcted and remote myocar-
ium in both acute and chronic infarctions. The new double
ontrast approach yields higher SI ratios (SI ratio 5.8 to 7.5)
han T2-triple inversion recovery imaging (SI ratio 2.9) (30).
This study confirms the results of previous studies (5,6)
hat the magnitude of enhancement of acute and chronic
nfarctions is identical after administration of extracellular
d-chelates, which eliminates the possibility of discrimi-
ating AMI from scar tissue. At the cellular level, Arheden
t al. (32) and Klein et al. (31) found in acute and chronic
nfarctions an almost 2-fold increase in distribution volume
f extracellular Gd-chelates compared with remote myocar-
ium. Thus, delayed enhancement after administration of
xtracellular Gd-chelates is independent of infarction age or
ifferences in cellular and microvascular structures. Delayed
nhancement in acute infarctions can be attributed to: 1) the
ncrease in extracellular space consequent to loss of mem-
rane integrity (32,33), and 2) delayed wash-out kinetics of
igure 3. Long-axis view T1-turbo spin echo images acquired at 3 days (le
s in the inversion recovery gradient echo sequence, both extracellular and
n acute infarctions (left panels). In chronic infarctions, the extracellular a
ntravascular agent (middle right panels). Accordingly, intravascular gadoxtracellular contrast media (34,35). sAt the microvascular level, leakage of intravascular Gd-
helates in acute infarctions is relatively slow compared with
xtracellular Gd-chelates (8–10,19,20,36–38). In recent
tudies (19,20), investigators found that intravascular Gd-
helates need 25 to 40 min to reach peak enhancement in
eperfused and occlusive infarctions, respectively, whereas
he extracellular Gd-chelates require 6 min. Thus, this is the
inimal time necessary to reliably exclude contrast en-
ancement of intravascular agents. The relatively slow
ransport of intravascular Gd-chelates shown in this and
revious studies can be explained by: 1) microvascular
bstruction (37,38), 2) high gradient pressure in the inter-
titium due to edema (9,37), and 3) slow convection process
ompared with passive diffusion transport (9,12,13,36). In a
revious study (8), changes in SI on T1-weighted spin echo
RI and histopathology were correlated in acute, subacute,
nd chronic infarctions. Karyolysis, cytoplasmic hypereosi-
ophilia, loss of myocytes striations, and intramyocardial
emorrage, suggesting microvascular damage, were ob-
erved in acute infarctions. In this pathological structure,
ntravascular agent provided differential enhancement. In
ubacute infarctions, the myocytes have been replaced by
eparative tissue consisting of fibroblasts and inflammatory
ells. Few microvessels were observed at the peri-infarction
one. On contrast-enhanced MRI, the enhancement of
ubacute infarctions was less pronounced compared with
cute infarctions. In chronic infarctions the myocytes had
volved to a dense fibrous scar with scarce microvessels. The
ntravascular agent produced no differential enhancement of
nels) and 8 weeks (right panels) from 2 animals (top and bottom rows).
vascular gadolinium-chelates produced differential enhancement (arrows)
roduced differential enhancement (far right panels, arrows), but not the
-chelate discriminates acute myocardial infarction from scar tissue.ft pa
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MR in AMIs and Scar Tissue November 21, 2006:1961–8howed thick-walled large blood vessels and scarce mi-
rovessels (Fig. 6).
The absence of delayed enhancement in chronic infarc-
ions after intravascular Gd-chelates can be attributed to the
resence of residual intact and/or remodeled microvessels,
hich retain intravascular Gd-chelates (11,14). Hong et al.
11) observed that small intramyocardial coronary arteries
ndergo remodeling with an increase in wall thickness and
decrease in lumen in swine model subjected to severe
yocardial ischemia. Poor vascularization and perfusion in
car tissue have also been demonstrated in scarred myocardium
ith fluorescent staining and microspheres, respectively
11,34). Wang et al. (13) observed a significant reduction in
otal vascular surface areas at 1 and 4 weeks after infarction.
his decline in vascular surface area was coupled with a 75%
ecrease in the number of microvessels in scarred myocar-
ium at 4 weeks after infarction.
The similar size of acute infarction demarcated by intra-
ascular and extracellular Gd-chelates suggests that both
gents are suitable for measuring the extent of acute
igure 4. Plots show average changes in signal intensity (SI) ratio after
dministration of the intravascular agent in acute and chronic infarctions
ith inversion recovery gradient echo (top) and T1–turbo spin echo
bottom) magnetic resonance imaging. On both sequences, the intravas-
ular agent significantly increased the SI ratio in acute but not chronic
nfarctions. *p  0.01 compared with baseline SI ratio in acute infarctions;
p 0.01 compared with SI ratio at 10 min; #p 0.01 SI ratio of chronic
ompared with acute infarctions.nfarction (19,20), but they differ with aging of the infarc-
a
mion, as this investigation has shown. The extent of infarc-
ion after administration of extracellular Gd-chelate was
maller at 8 weeks than at 3 days. Such a decline in the
xtent of infarction has been shown clinically (39) and
xperimentally (6).
tudy limitations. A limiting factor of the current study is
hat infarcts of only 2 time durations (3 days and 8 weeks)
ere studied. Eight weeks after infarction seems reasonable,
ecause it has been widely considered chronic infarction in
umans and animals (21–24). The use of 2 MR contrast
edia for discriminating acute from chronic infarctions is
ather time consuming, and this might limit the clinical
pplication.
igure 5. Histograms show the signal intensity (SI) ratios after adminis-
ration of the intravascular (top) and extracellular (bottom) gadolinium-
helates. T2–turbo spin echo (TSE) and the intravascular agent provided
ifferential enhancement of acute (black bars) but not chronic (white bars)
nfarctions on T1-TSE and sequences. The extracellular agent provided the
ame magnitude of enhancement in acute and chronic infarctions on
1-TSE and inversion recovery gradient echo (IR-GRE) sequences. Note
hat contrast enhanced IR-GRE sequence provides better contrast than
oth T1-TSE and T2-TSE sequences. *p  0.01 SI ratios compared with
cute infarctions. p  0.01 SI ratios compared with contrast enhanced
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November 21, 2006:1961–8 MR in AMIs and Scar Tissueractical application. The current and previously reported
pproaches (29,31) might provide the means to age MIs.
e propose that discrimination of AMIs from scar tissue
an be done in the following manner: 1) in AMIs, there is
elayed enhancement by both intravascular and extracellular
d-chelates; and 2) in chronic infarctions, there is delayed
nhancement by extracellular but not by intravascular Gd-
helates. We conclude that if there is no delayed enhance-
ent after administration of intravascular Gd-chelates, it is
ot an acute infarction. Standard extracellular agents would
lso be preferable for discriminating nonviable from stun-
ing and hibernating myocardium in cases of ischemic
ardiomyopathy (1).
eprint requests and correspondence: Dr. Maythem Saeed,
epartment of Radiology, University of California San Francisco,
13 Parnassus Avenue, HSW 207B, San Francisco, California
4134-0628. E-mail: Maythem.Saeed@radiology.UCSF.edu.
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